These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33059564)

  • 1. The Undiscovered Potential of Essential Oils for Treating SARS-CoV-2 (COVID-19).
    Wilkin PJ; Al-Yozbaki M; George A; Gupta GK; Wilson CM
    Curr Pharm Des; 2020; 26(41):5261-5277. PubMed ID: 33059564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties.
    Asif M; Saleem M; Saadullah M; Yaseen HS; Al Zarzour R
    Inflammopharmacology; 2020 Oct; 28(5):1153-1161. PubMed ID: 32803479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential Oils and COVID-19.
    Elsebai MF; Albalawi MA
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36431995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral Essential Oils Incorporated in Nanocarriers: Strategy for Prevention from COVID-19 and Future Infectious Pandemics.
    Kaur M; Devi G; Nagpal M; Singh M; Dhingra GA; Aggarwal G
    Pharm Nanotechnol; 2020; 8(6):437-451. PubMed ID: 33069206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An updated and comprehensive review of the antiviral potential of essential oils and their chemical constituents with special focus on their mechanism of action against various influenza and coronaviruses.
    Wani AR; Yadav K; Khursheed A; Rather MA
    Microb Pathog; 2021 Mar; 152():104620. PubMed ID: 33212200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Landscape of Natural Products against Coronaviruses: Perspectives in COVID-19 Treatment and Anti-viral Mechanism.
    Shawon J; Akter Z; Hossen MM; Akter Y; Sayeed A; Junaid M; Afrose SS; Khan MA
    Curr Pharm Des; 2020; 26(41):5241-5260. PubMed ID: 33155902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Update of Phytotherapeutic Agents in the Treatment of COVID-19:
    Ramesh V; Kulkarni SA; Velusamy P; Devadasan V; Devaraju P; Rajnish KN; Madhavan T; Anbu P; Ramasamy P; Sundarraj R
    Front Biosci (Landmark Ed); 2022 Apr; 27(4):123. PubMed ID: 35468682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial Natural Products with Antiviral Activities, Including Anti-SARS-CoV-2: A Review.
    Frediansyah A; Sofyantoro F; Alhumaid S; Al Mutair A; Albayat H; Altaweil HI; Al-Afghani HM; AlRamadhan AA; AlGhazal MR; Turkistani SA; Abuzaid AA; Rabaan AA
    Molecules; 2022 Jul; 27(13):. PubMed ID: 35807550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19: morphology and mechanism of the SARS-CoV-2, global outbreak, medication, vaccines and future of the virus.
    Bhattacharyya P; Das S; Aich S; Sarkar J
    Front Biosci (Elite Ed); 2021 Dec; 13(2):272-290. PubMed ID: 34937314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanostructured lipid carriers loaded with essential oils: a strategy against SARS-CoV-2.
    Almeida LF; Gil GA; Moraes LN; Furtado FB; Kakuda L; Grotto RMT; Oliveira WP
    J Microencapsul; 2024 Jun; 41(4):284-295. PubMed ID: 38686964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural products can be used in therapeutic management of COVID-19: Probable mechanistic insights.
    Ali S; Alam M; Khatoon F; Fatima U; Elasbali AM; Adnan M; Islam A; Hassan MI; Snoussi M; De Feo V
    Biomed Pharmacother; 2022 Mar; 147():112658. PubMed ID: 35066300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of traditional ayurvedic Kadha for prevention and management of the novel Coronavirus (SARS-CoV-2) using in silico approach.
    Maurya DK; Sharma D
    J Biomol Struct Dyn; 2022 Jun; 40(9):3949-3964. PubMed ID: 33251972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy.
    Mirtaleb MS; Mirtaleb AH; Nosrati H; Heshmatnia J; Falak R; Zolfaghari Emameh R
    Biomed Pharmacother; 2021 Jun; 138():111518. PubMed ID: 33774315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of phytoconstituents in the management of COVID-19.
    Das A; Pandita D; Jain GK; Agarwal P; Grewal AS; Khar RK; Lather V
    Chem Biol Interact; 2021 May; 341():109449. PubMed ID: 33798507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the anti-SARS-CoV-2 properties of essential oils and aromatic extracts.
    Strub DJ; Talma M; Strub M; Rut W; Zmudzinski M; Brud W; Neyts J; Vangeel L; Zhang L; Sun X; Lv Z; Nayak D; Olsen SK; Hilgenfeld R; Jochmans D; Drąg M
    Sci Rep; 2022 Aug; 12(1):14230. PubMed ID: 35987981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication
    Shytaj IL; Fares M; Gallucci L; Lucic B; Tolba MM; Zimmermann L; Adler JM; Xing N; Bushe J; Gruber AD; Ambiel I; Taha Ayoub A; Cortese M; Neufeldt CJ; Stolp B; Sobhy MH; Fathy M; Zhao M; Laketa V; Diaz RS; Sutton RE; Chlanda P; Boulant S; Bartenschlager R; Stanifer ML; Fackler OT; Trimpert J; Savarino A; Lusic M
    mBio; 2022 Apr; 13(2):e0370521. PubMed ID: 35229634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An exhaustive comprehension of the role of herbal medicines in Pre- and Post-COVID manifestations.
    Prajapati SK; Malaiya A; Mishra G; Jain D; Kesharwani P; Mody N; Ahmadi A; Paliwal R; Jain A
    J Ethnopharmacol; 2022 Oct; 296():115420. PubMed ID: 35654349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. West African medicinal plants and their constituent compounds as treatments for viral infections, including SARS-CoV-2/COVID-19.
    Popoola TD; Segun PA; Ekuadzi E; Dickson RA; Awotona OR; Nahar L; Sarker SD; Fatokun AA
    Daru; 2022 Jun; 30(1):191-210. PubMed ID: 35476297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options.
    Chakraborty C; Sharma AR; Sharma G; Bhattacharya M; Lee SS
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):4016-4026. PubMed ID: 32329877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.